𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection

✍ Scribed by Martin Lagging; Åsa Alsiö; Nina Langeland; Court Pedersen; Martti Färkkilä; Mads Rauning Buhl; Kristine Mørch; Kristoffer Hellstrand; Gunnar Norkrans

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
632 KB
Volume
53
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.

📜 SIMILAR VOLUMES

Usefulness of simple assays for serum co
Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy
✍ Toshio Suzuki; Eiji Tanaka; Akihiro Matsumoto; Akihiko Urushihara; Takeshi Sodey 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4

Assessment of early virological response
Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: Implications for clinical management of patients with chronic hepatitis C virus infection
✍ Philippe Halfon; Guillaume Pénaranda; Marc Bourlière; Hacène Khiri; Marie-France 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views

WHO International Standards for nucleic acid tests are used widely to compare the different assays used in HCV RNA quantitation. The aim of the study was to assess the impact of the international unit standard for measuring HCV RNA in the management of patients with chronic hepatitis C virus (HCV) i

A mutation in the interferon sensitivity
A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b
✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon

Determinants of relapse after a short (1
Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection
✍ Alessandra Mangia; Nicola Minerva; Donato Bacca; Raffaele Cozzolongo; Ernesto Ag 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

In hepatitis C virus (HCV) genotypes 2 and 3 patients, the high rate of relapse after 12 to 16 weeks of antiviral therapy is the main concern for shortening treatment duration. This study was undertaken to delineate predictors of relapse after short treatment in patients with undetectable HCV RNA at